Myocarditis following rAd26 and rAd5 vector-based COVID-19 vaccine: case report.
ESC Heart Fail
; 9(2): 1483-1486, 2022 04.
Article
en En
| MEDLINE
| ID: mdl-35106967
ABSTRACT
SARS-CoV-2 vaccines provide a safe solution with a major impact on reducing the spread of the virus and mild side effects. Research has shown rare cases of myocarditis after mRNA vaccines. This study presents a 29-year-old male with chest pain after 48 h of receiving rAd26 and rAd5 vector-based COVID-19 vaccine (Sputnik V vaccine). The electrocardiogram revealed ST-segment elevation. Also, the laboratory screening was remarkable for elevated cardiac Troponin-I level, and leukocytosis; and echocardiography depicted severe left ventricular systolic dysfunction. Overall, endomyocardial biopsy proved lymphocytic myocarditis such that the patient was successfully treated with immunosuppressive and guideline-directed medical treatment.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
COVID-19
/
Miocarditis
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Guideline
Límite:
Adult
/
Humans
/
Male
Idioma:
En
Año:
2022
Tipo del documento:
Article